The New, Stringent MDR and IVDR Regulations: Viewing this Change as an Opportunity

Biotechnet Switzerland

Authors

  • Elsbeth Heinzelmann Journalist science and technology

DOI:

https://doi.org/10.2533/chimia.2018.430

Abstract

The healthcare and life science sector is growing inexorably, and is now a multi-billion dollar industry. In 2016 the companies in this sector posted sales of USD 140 billion, and their profitability more than doubled by comparison with 2010. The pharmaceutical, diagnostics, medtech and chemical sectors have become Switzerland's most powerful export industry, and significant number of approved medications and diagnostics contain biotech elements.
CHIMIA Vol. 72 No. 06(2018): CHIRALITY: Symmetries and Asymmetries

Downloads

Published

2018-06-27

Issue

Vol. 72 No. 6 (2018): CHIRALITY: Symmetries and Asymmetries

Section

Columns, Conference Reports

Categories

License

Copyright (c) 2018 Swiss Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

[1]
E. Heinzelmann, Chimia 2018, 72, 430, DOI: 10.2533/chimia.2018.430.